Ofloxacine Viatris

Ofloxacin, the active ingredient in Ofloxacine Viatris, is a fluoroquinolone presented as an ear drop solution for auricular use. It treats external ear infections such as otitis externa in patients requiring antibacterial therapy.

GNH USA supplies Ofloxacine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections of the external ear.

- Otitis externa: Reduces bacterial load and alleviates inflammation in the ear canal. - Other external ear infections: Provides antibacterial activity against susceptible organisms causing ear canal infections. - Bacterial otitis media (off‑label): May be employed under specialist guidance for middle‑ear bacterial infections when topical therapy is appropriate.

Ofloxacine Viatris may cause a range of adverse reactions, most of which are localized to the ear.

Common Side Effects: - Ear discomfort or burning sensation. - Itching or mild pain in the treated ear. - Transient hearing changes or muffled hearing. - Local irritation or redness of the ear canal. - Headache. - Nausea.

Serious or Rare Side Effects: - Allergic reactions such as rash, swelling, or anaphylaxis. - Severe ototoxicity leading to permanent hearing loss. - Tendon rupture or tendonitis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vision disturbances. - Central nervous system effects such as seizures.

Before using Ofloxacine Viatris, consider the following safety measures.

- Allergy assessment: Verify no known hypersensitivity to fluoroquinolones. - Indication confirmation: Use only for approved external ear infections. - Duration limit: Avoid prolonged treatment beyond prescribed period. - Tendon monitoring: Discontinue if tendon pain or swelling occurs. - Concomitant ototoxic drugs: Use with caution when combined with other ototoxic agents. - Store at room temperature: Keep in the original container, protect from moisture and light.

Ofloxacin can interact with several medicines; categorize them by clinical relevance.

Major Interactions (Avoid): - Antacids or supplements containing magnesium or aluminum: Reduce absorption of ofloxacin. - Warfarin: May increase anticoagulant effect and bleeding risk. - Systemic corticosteroids: Heighten risk of tendon rupture. - Theophylline: Potentially increase plasma theophylline concentrations.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): May increase tendon injury risk. - Diabetic agents: May cause hypoglycemia. - Other fluoroquinolones: Additive toxicity risk. - Cyclosporine: Possible increase in cyclosporine levels.